AACE AME ETA甲状腺结节诊治指南文档格式.docx

AACE AME ETA甲状腺结节诊治指南文档格式.docx

《AACE AME ETA甲状腺结节诊治指南文档格式.docx》由会员分享，可在线阅读，更多相关《AACE AME ETA甲状腺结节诊治指南文档格式.docx（25页珍藏版）》请在冰豆网上搜索。

4928-4934.[EL 

1]124.HegedusL,NygaardB,HansenJM.Isroutinethyroxinetreatmenttohinderpostoperativerecurrenceofnontoxicgoiterjustified?

JClinEndocrinolMetab.1999;

84:

756760.[EL2]125.MoalemJ,SuhI,DuhQY.Treatmentandpreventionofrecurrenceofmultinodulargoiter:

anevidence-basedreviewoftheliterature.WorldJSurg.2008;

32:

1301-1312.[EL4]126.FaberJ,GalloeAM.ChangesinbonemassduringprolongedsubclinicalhyperthyroidismduetoL-thyroxinetreatment:

ameta-analysis.EurJEndocrinol.1994;

130:

350-356.[EL1]127.UzzanB,CamposJ,CucheratM,NonyP,BoisselJP,PerretGY.Effectsonbonemassoflongtermtreatmentwiththyroidhormones:

Ameta-analysis.JClinEndocrinolMetab.1996;

4278-4289.[EL1]128.SawinCT,GellerA,WolfPA,etal.Lowserumthyrotropinconcentrationsasariskfactorforatrialfibrillationinolderpersons.NEnglJMed.1994;

331:

1249-1252.[EL2]129.ParleJV,MaisonneuveP,SheppardMC,BoyleP,FranklynJA.Predictionofall-causeandcardiovascularmortalityinelderlypeoplefromonelowserumthyrotropinresult:

A10-yearcohortstudy.Lancet.2001;

358:

861-865.[EL2]130.LaRosaGL,LupoL,GiuffridaD,GulloD,VigneriR,BelfioreA.Levothyroxineandpotassiumiodidearebotheffectiveintreatingbenignsolitarysolidcoldnodulesofthethyroid.AnnInternMed.1995;

122:

1-8.[EL2]131.MiccoliP,MinutoMN,UgoliniC,PisanoR,FossoA,BertiP.Minimallyinvasivevideo-assistedthyroidectomyforbenignthyroiddisease:

Anevidence-basedreview.WorldJSurg.2008;

1333-1340.[EL4—review]132.AlvaradoR,McMullenT,SidhuSB,DelbridgeLW,SywakMS.Minimallyinvasivethyroidsurgeryforsinglenodules:

anevidence-basedreviewofthelateralmini-incisiontechnique.WorldJSurg.2008;

1341-1348.[EL4—review]133.LivraghiT,ParacchiA,FerrariC,etal.Treatmentofautonomousthyroidnoduleswithpercutaneousethanolinjection:

preliminaryresults:

workinprogress.Radiology.1990;

175:

827-829.[EL4]134.PacellaCM,BizzarriG,GuglielmiR,etal.Thyroidtissue:

US-guidedpercutaneousinterstitiallaserablation:

afeasibilitystudy.Radiology.2000;

217:

673-677.[EL3]135.VerdeG,PapiniE,PacellaCM,etal.Ultrasoundguidedpercutaneousethanolinjectioninthetreatmentofcysticthyroidnodules.ClinEndocrinol（Oxf.1994;

41:

719-724.[EL1]136.GuglielmiR,PacellaCM,BianchiniA,etal.Percutaneousethanolinjectiontreatmentinbenignthyroidlesions:

roleandefficacy.Thyroid.2004;

14:

125-131.[EL2]137.ValcaviR,FrasoldatiA.Ultrasound-guidedpercutaneousethanolinjectiontherapyinthyroidcysticnodules.EndocrPract.2004;

10:

269-275.[EL3]138.KimJH,LeeHK,LeeJH,AhnIM,ChoiCG.Efficacyofsonographicallyguidedpercutaneousethanolinjectionfortreatmentofthyroidcystsversussolidthyroidnodules.AJRAmJRoentgenol.2003;

180:

1723-1726.[EL3]139.ZingrilloM,TorlontanoM,ChiarellaR,etal.Percutaneousethanolinjectionmaybeadefinitivetreatmentforsymptomaticthyroidcysticnodulesnottreatablebysurgery:

Five-yearfollow-upstudy.Thyroid.1999;

9:

763-767.[EL3]140.BennedbaekFN,HegedusL.Treatmentofrecurrentthyroidcystswithethanol:

Arandomizeddouble-blindcontrolledtrial.JClinEndocrinolMetab.2003;

88:

5773-5777.[EL1]141.LippiF,FerrariC,ManettiL,etal;

theMulticenterStudyGroup.Treatmentofsolitaryautonomousthyroidnodulesbypercutaneousethanolinjection:

ResultsofanItalianmulticenterstudy.JClinEndocrinolMetab.1996;

32613264.[EL3]142.LivraghiT,ParacchiA,FerrariC,ReschiniE,MacchiRM,BonifacinoA.Treatmentofautonomousthyroidnoduleswithpercutaneousethanolinjection:

4-yearexperience.Radiology.1994;

190:

529-533.[EL3]143.ZingrilloM,ColluraD,GhiggiMR,NirchioV,TrischittaV.Treatmentoflargecoldbenignthyroidnodulesnoteligibleforsurgerywithpercutaneousethanolinjection.JClinEndocrinolMetab.1998;

3905-3907.[EL3]144.BennedbaekFN,NielsenLK,HegedusL.EffectofpercutaneousethanolinjectiontherapyversussuppressivedosesofL-thyroxineonbenignsolitarysolidcoldthyroidnodules:

Arandomizedtrial.JClinEndocrinolMetab.1998;

830-835.[EL1]145.KimYS,RhimH,TaeK,ParkDW,KimST.Radiofrequencyablationofbenigncoldthyroidnodules:

Initialclinicalexperience.Thyroid.2006;

16:

361-367.[EL4]146.SpieziaS,GarberoglioR,MiloneF,etal.Thyroidnodulesandrelatedsymptomsarestablycontrolledtwoyearsafterradiofrequencythermalablation.Thyroid.2009;

19:

219225.[EL3]147.DossingH,BennedbaekFN,HegedusL.Effectofultrasound-guidedinterstitiallaserphotocoagulationonbenignsolitarysolidcoldthyroidnodules:

Oneversusthreetreatments.Thyroid.2006;

763-768.[EL3]148.DossingH,BennedbaekFN,HegedusL.Effectofultrasound-guidedinterstitiallaserphotocoagulationonbenignsolitarysolidcoldthyroidnodules:

Arandomisedstudy.EurJEndocrinol.2005;

152:

341-345.[EL2]149.PapiniE,GuglielmiR,BizzarriG,etal.Treatmentofbenigncoldthyroidnodules:

Arandomizedclinicaltrialofpercutaneouslaserablationversuslevothyroxinetherapyorfollow-up.Thyroid.2007;

17:

229-235.[EL1]150.CakirB,UgrasNS,GulK,ErsoyR,KorukluogluB.Initialreportoftheresultsofpercutaneouslaserablationofbenigncoldthyroidnodules:

Evaluationofhistopathologicalchangesafter2years.EndocrPathol.2009;

20:

170-176.[EL 

3]151.MeierDA,BrillDR,BeckerDV,etal;

SocietyofNuclearMedicine.Procedureguidelinefortherapyofthyroiddiseasewith（131iodine.JNuclMed.2002;

43:

856-861.[EL3—guidelines]

42AACE/AME/ETAThyroidNoduleGuidelines,EndocrPract.2010;

16（Suppl1152.NygaardB,HegedusL,NielsenKG,UlriksenP,HansenJM.Long-termeffectofradioactiveiodineonthyroidfunctionandsizeinpatientswithsolitaryautonomouslyfunctioningtoxicthyroidnodules.ClinEndocrinol（Oxf.1999;

50:

197-202.[EL3]153.DietleinM,DresslerJ,GrunwaldF,etal;

DeutscheGesellschaftfü

rNuklearmedizin.Guidelineforradioiodinetherapyforbenignthyroiddiseases（version4[articleinGerman].Nuklearmedizin.2007;

46:

220-223.[EL 

4—guidelines]154.ReinersC,SchneiderP.Radioiodinetherapyofthyroidautonomy.EurJNuclMedMolImaging.2002;

29（Suppl2:

S471-S478.[EL3]155.MetsoS,JaatinenP,HuhtalaH,AuvinenA,OksalaH,SalmiJ.Increasedcardiovascularandcancermortalityafterradioiodinetreatmentforhyperthyroidism[erratumin:

JClinEndocrinolMetab.2007;

92:

4008].JClinEndocrinolMetab.2007;

2190-2196.[EL2]156.RonE,DoodyMM,BeckerDV,etal;

CooperativeThyrotoxicosisTherapyFollow-upStudyGroup.Cancermortalityfollowingtreatmentforadulthyperthyroidism.JAMA.1998;

280:

347-355.[EL3]157.CeccarelliC,BencivelliW,VittiP,GrassoL,PincheraA.Outcomeofradioiodine-131therapyinhyperfunctioningthyroidnodules:

A20years’retrospectivestudy.ClinEndocrinol（Oxf.2005;

62:

331-335.[EL3]158.NygaardB,FaberJ,VejeA,HegedisL,HansenJM.Transitionofnodulartoxicgoitertoautoimmunehyperthyroidismtriggeredby131Itherapy.Thyroid.1999;

477481.[EL3]159.NygaardB,KnudsenJH,HegedusL,ScientAV,HansenJE.ThyrotropinreceptorantibodiesandGraves’disease,aside-effectof131Itreatmentinpatientswithnontoxicgoiter.JClinEndocrinolMetab.1997;

82:

2926-2930.[EL3]160.WallaschofskiH,MullerD,GeorgiP,PaschkeR.InductionofTSH-receptorantibodiesinpatientswithtoxicmultinodulargoitrebyradioiodinetreatment.HormMetabRes.2002;

34:

36-39.[EL3]161.VosXG,SmitN,EndertE,BrosschotJF,TijssenJG,WiersingaWM.AgeandstressasdeterminantsoftheseverityofhyperthyroidismcausedbyGraves’diseaseinnewlydiagnosedpatients.EurJEndocrinol.2009;

160:

193199.[EL3]162.BonnemaSJ,BennedbaekFN,VejeA,MarvingJ,HegedusL.Propylthiouracilbefore131Itherapyofhyperthyroiddiseases:

effectoncurerateevaluatedbyarandomizedclinicaltrial.JClinEndocrinolMetab.2004;

89:

44394444.[EL 

2]163.WalterMA,BrielM,Christ-CrainM,etal.Effectsofantithyroiddrugsonradioiodinetreatment:

systematicreviewandmeta-analysisofrandomisedcontrolledtrials.BMJ.2007;

334:

514.[EL1]164.WeetmanAP.Radioiodinetreatmentforbenignthyroiddiseases.ClinEndocrinol（Oxf.2007;

66:

757-764.[EL4—review]165.HegedusL,HansenBM,KnudsenN,HansenJM.Reductionofsizeofthyroidwithradioactiveiodineinmultinodularnon-toxicgoitre.BMJ.1988;

297:

661-662.[EL3]166.NygaardB,HegedusL,GervilM,HjalgrimH,SoeJensenP,HansenJM.Radioiodinetreatmentofmultinodularnon-toxicgoitre.BMJ.1993;

307:

828-832.[EL3]167.HuysmansDA,HermusAR,CorstensFH,BarentszJO,KloppenborgPW.Large,compressivegoiterstreatedwithradioiodine.AnnInternMed.1994;

121:

757-762.[EL